CN Patent

CN107638571B — 一种特考韦瑞口服药物组合物及其制备方法

Assigned to China Biotechnology Co ltd · Expires 2021-07-06 · 5y expired

What this patent protects

本发明涉及一种药物组合物，含有特考韦瑞、环糊精和附加剂，以及任选地药学上可接受的辅料。还涉及该药物组合物的制备方法。该组合物通过联合使用环糊精和葡甲胺，比单独使用环糊精或单独使用葡甲胺，大大提高了特考韦瑞的水中溶解度和溶出度。且具有处方简单、易操作、质量稳定、可控性强、重现性好等优点。

USPTO Abstract

本发明涉及一种药物组合物，含有特考韦瑞、环糊精和附加剂，以及任选地药学上可接受的辅料。还涉及该药物组合物的制备方法。该组合物通过联合使用环糊精和葡甲胺，比单独使用环糊精或单独使用葡甲胺，大大提高了特考韦瑞的水中溶解度和溶出度。且具有处方简单、易操作、质量稳定、可控性强、重现性好等优点。

Drugs covered by this patent

Patent Metadata

Patent number: CN107638571B
Jurisdiction: CN
Classification: —
Expires: 2021-07-06
Drug substance claim: No
Drug product claim: No
Assignee: China Biotechnology Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.